Literature DB >> 18572100

Differential transcriptional modulation of biological processes in adipocyte triglyceride lipase and hormone-sensitive lipase-deficient mice.

Montserrat Pinent1, Hubert Hackl, Thomas Rainer Burkard, Andreas Prokesch, Christine Papak, Marcel Scheideler, Günter Hämmerle, Rudolf Zechner, Zlatko Trajanoski, Juliane Gertrude Strauss.   

Abstract

Adipocyte triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) are intracellular lipases that mobilize triglycerides, the main energy source in mammals. Deletion of genes encoding ATGL (Pnpla2) or HSL (Lipe) in mice results in striking phenotypic differences, suggesting distinct roles for these lipases. The goal of the present study was to identify the biological processes that are modulated in the metabolic tissues of ATGL- and HSL-deficient mice. DNA microarrays were employed to provide full genome coverage concerning the types of genes that are differentially expressed in wild-type and mutant mice. For both mouse models, transcript signatures were identified in white adipose tissue, brown adipose tissue (BAT), skeletal muscle (SM), cardiac muscle (CM), and liver. Genetic ablation of ATGL and HSL alters the transcript levels of a large number of genes in metabolic tissues. The genes affected in the two models are, however, largely different ones. Indeed, only one biological process was modulated in the same way in both mouse models, namely the down-regulation of fatty acid metabolism in BAT. The most pronounced modulation of biological processes was observed in ATGL-/- CM, in which a concerted down-regulation of transcripts associated with oxidative pathways was observed. In HSL-/- mice, in contrast, the most marked changes were seen in SM, namely, alterations in transcript levels reflecting a change of energy source from lipid to carbohydrate. The transcript signatures also provided novel insights into the metabolic derangements that are characteristic of ATGL-/- mice. Our findings suggest that ATGL and HSL differentially modulate biological processes in metabolic tissues. We hypothesize that the intermediary metabolites of the lipolytic pathways are signaling molecules and activators of a wide range of biochemical and cellular processes in mammals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18572100     DOI: 10.1016/j.ygeno.2008.03.010

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  20 in total

Review 1.  Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling.

Authors:  Rosalind A Coleman; Douglas G Mashek
Journal:  Chem Rev       Date:  2011-06-01       Impact factor: 60.622

2.  Adipose triglyceride lipase deletion from adipocytes, but not skeletal myocytes, impairs acute exercise performance in mice.

Authors:  John J Dubé; Mitch T Sitnick; Gabriele Schoiswohl; Rachel C Wills; Mahesh K Basantani; Lingzhi Cai; Thomas Pulinilkunnil; Erin E Kershaw
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-03-17       Impact factor: 4.310

3.  Dihydroartemisinin transiently activates the JNK/SAPK signaling pathway in endothelial cells.

Authors:  Fengyun Dong; Ju Han; Guoxian Jing; Xiaocui Chen; Suhua Yan; Longtao Yue; Zhiqun Cao; Xiaochun Liu; Guozhao Ma; Ju Liu
Journal:  Oncol Lett       Date:  2016-10-05       Impact factor: 2.967

4.  Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning.

Authors:  Kuok Teong Ong; Mara T Mashek; So Young Bu; Andrew S Greenberg; Douglas G Mashek
Journal:  Hepatology       Date:  2010-10-21       Impact factor: 17.425

Review 5.  iPS cell modeling of cardiometabolic diseases.

Authors:  Kenta Nakamura; Ken-ichi Hirano; Sean M Wu
Journal:  J Cardiovasc Transl Res       Date:  2012-10-16       Impact factor: 4.132

6.  Early structural and metabolic cardiac remodelling in response to inducible adipose triglyceride lipase ablation.

Authors:  Petra C Kienesberger; Thomas Pulinilkunnil; Jeevan Nagendran; Martin E Young; Juliane G Bogner-Strauss; Hubert Hackl; Rammy Khadour; Emma Heydari; Guenter Haemmerle; Rudolf Zechner; Erin E Kershaw; Jason R B Dyck
Journal:  Cardiovasc Res       Date:  2013-05-25       Impact factor: 10.787

7.  Functional analysis of long-chain acyl-CoA synthetase 1 in 3T3-L1 adipocytes.

Authors:  Sandra Lobo; Brian M Wiczer; David A Bernlohr
Journal:  J Biol Chem       Date:  2009-05-08       Impact factor: 5.157

8.  Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity.

Authors:  So Young Bu; Mara T Mashek; Douglas G Mashek
Journal:  J Biol Chem       Date:  2009-09-08       Impact factor: 5.157

9.  Common variants associated with changes in levels of circulating free fatty acids after administration of glucose-insulin-potassium (GIK) therapy in the IMMEDIATE trial.

Authors:  K L Ellis; Y Zhou; L Rodriguez-Murillo; J R Beshansky; E Ainehsazan; H P Selker; G S Huggins; L A Cupples; I Peter
Journal:  Pharmacogenomics J       Date:  2015-12-08       Impact factor: 3.550

Review 10.  Novel insights into adipogenesis from omics data.

Authors:  Andreas Prokesch; Hubert Hackl; Robab Hakim-Weber; Stefan R Bornstein; Zlatko Trajanoski
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.